IP Library › Assignment 056234/0019
Patent Assignment
Reel/Frame 056234/0019

Assignment of Assignor's Interest

Recorded: 2021-05-13 Pages: 8
Assignors
ERICKSON, MARY
Executed: 2012-08-01
LITZINGER, DAVID C.
Executed: 2012-07-31
GHOSH, SOUMITRA S.
Executed: 2012-09-26
GUO, ZIJIAN
Executed: 2012-07-31
ROTH, JONATHAN DAVID
Executed: 2012-07-30
Assignee
AMYLIN PHARMACEUTICALS, INC.
9360 TOWNE CENTRE DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (2)
Engineered Polypeptides Having Enhanced Duration of Action
Application: 14/800,537 →
Publication: US 2016/0137709
Engineered Polypeptides Having Enhanced Duration of Action
Application: 16/751,538 →
Publication: US 2020/0362006
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement Jun 15, 2016
From: AEGERION PHARMACEUTICALS, INC.
To: QLT INC.
Reel/Frame 039024/0965 →
Security Agreement Jun 16, 2016
From: AEGERION PHARMACEUTICALS, INC.
To: SILICON VALLEY BANK
Reel/Frame 039050/0882 →
Release of Security Interest Nov 30, 2016
From: SILICON VALLEY BANK
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 040748/0974 →
Change of Name Mar 16, 2018
From: QLT INC.
To: NOVELION THERAPEUTICS INC.
Reel/Frame 045619/0257 →
Patent Security Agreement Apr 6, 2018
From: AEGERION PHARMACEUTICALS, INC.
To: NOVELION THERAPEUTICS INC.
Reel/Frame 045853/0148 →
Patent Security Agreement May 1, 2018
From: AEGERION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS AGENT
Reel/Frame 046087/0756 →
Patent Security Agreement Sep 24, 2018
From: AEGERION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS AGENT
Reel/Frame 047130/0176 →
Security Interest Nov 8, 2018
From: AEGERION PHARMACEUTICALS, INC.
To: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
Reel/Frame 047447/0926 →
Release of Security Interest Nov 12, 2018
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 047474/0398 →
Release of Security Interest Sep 24, 2019
From: NOVELION THERAPEUTICS INC.
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 050478/0844 →
Security Interest Sep 24, 2019
From: AEGERION PHARMACEUTICALS, INC.
To: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
Reel/Frame 050478/0204 →
Release of Security Interest Sep 24, 2019
From: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 050478/0629 →
Release of Security Interest Sep 24, 2019
From: NOVELION THERAPEUTICS INC. (F/K/A QLT, INC.)
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 050478/0738 →
Assignment of Assignor's Interest Feb 16, 2022
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 059142/0420 →
Assignment of Assignor's Interest Feb 16, 2022
From: AMYLIN PHARMACEUTICALS, LLC; ASTRAZENECA PHARMACEUTICALS LP
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 059142/0541 →
Change of Name Feb 16, 2022
From: AEGERION PHARMACEUTICALS, INC.
To: AMRYT PHARMACEUTICALS INC.
Reel/Frame 059142/0537 →
Change of Name Feb 16, 2022
From: AMYLIN PHARMACEUTICALS, INC.
To: AMYLIN PHARMACEUTICALS, LLC
Reel/Frame 059142/0378 →
Security Interest Feb 18, 2022
From: AMRYT PHARMACEUTICALS, INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 059049/0164 →
Release of Security Interest Feb 23, 2022
From: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
To: AEGERION PHARMACEUTICALS, INC.; AMRYT RESEARCH LIMITED
Reel/Frame 059074/0604 →
Release of Security Interest Apr 13, 2023
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: AMRYT GENETICS LIMITED; AMRYT PHARMACEUTICALS, INC.; AMRYT ENDO, INC.; AMRYT RESEARCH LIMITED
Reel/Frame 063318/0849 →